264 related articles for article (PubMed ID: 6158934)
1. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
Artery; 1980; 8(1):73-9. PubMed ID: 6158934
[TBL] [Abstract][Full Text] [Related]
2. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
[TBL] [Abstract][Full Text] [Related]
4. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
5. Chemistry, measurement, and clinical significance of platelet specific proteins.
de Boer AC; Genton E; Turpie AG
Crit Rev Clin Lab Sci; 1982; 18(2):183-211. PubMed ID: 6185275
[No Abstract] [Full Text] [Related]
6. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
[TBL] [Abstract][Full Text] [Related]
7. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
Al-Mondhiry H; Pierce WS; Pennock JL
J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
[TBL] [Abstract][Full Text] [Related]
8. [Platelet-specific proteins in arteriosclerosis and coronary disease].
Musiał J
Kardiol Pol; 1980; 23(8):707-13. PubMed ID: 6158591
[No Abstract] [Full Text] [Related]
9. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age.
Yamanishi J; Sano H; Saito K; Furuta Y; Fukuzaki H
Thromb Haemost; 1985 Aug; 54(2):539-43. PubMed ID: 2417354
[TBL] [Abstract][Full Text] [Related]
10. Beta-TG and plasma catecholamines levels after sympathetic stimuli in hypertensives and patients with peripheral vascular disease.
Catalano M; Russo U; Belletti S; Colombo F; Belloni A; del Rosso G; Lombardi F; Libretti A
Thromb Haemost; 1990 Jun; 63(3):383-5. PubMed ID: 2144920
[TBL] [Abstract][Full Text] [Related]
11. [Determination of the level of plasma beta-thromboglobulin in diabetes].
Stoltz JF; Voisin P; Drouin P; Pointel JP; Benisti G
Biomedicine; 1980; 33(6):194-6. PubMed ID: 6163487
[TBL] [Abstract][Full Text] [Related]
12. [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].
Lokiec F; Najean Y
Nouv Presse Med; 1980 Oct; 9(38):2833-4, 2837-8. PubMed ID: 6160454
[TBL] [Abstract][Full Text] [Related]
13. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
[No Abstract] [Full Text] [Related]
14. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
Ferri GM; Afeltra A; Caccavo D; Amoroso A
Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
[No Abstract] [Full Text] [Related]
15. Platelet activation in patients with chronic pulmonary heart disease. Effect of dipyridamole treatment.
Zhang X; Ling P
Chin Med J (Engl); 1995 Feb; 108(2):95-7. PubMed ID: 7774397
[TBL] [Abstract][Full Text] [Related]
16. PF,VIII/vWF,B-TG and PF4 in diabetic subjects, both type 1 and 2, with and without retinopathy.
Guastamacchia E; Di Paolo S; Santoro G; Damato A; Nardelli GM; Giorgino R
Boll Soc Ital Biol Sper; 1985 Apr; 61(4):499-505. PubMed ID: 2412573
[No Abstract] [Full Text] [Related]
17. Correlation of specific platelet activation markers with carotid arterial wall thickness.
Ghaddar HB; Cortes J; Salomaa V; Kark JD; Davis CE; Folsom AR; Heiss G; Stinson V; Wu KK
Thromb Haemost; 1995 Sep; 74(3):943-8. PubMed ID: 8571326
[TBL] [Abstract][Full Text] [Related]
18. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation.
Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM
Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020
[TBL] [Abstract][Full Text] [Related]
19. Increased platelet activity in patients with isolated coronary artery ectasia.
Yasar AS; Erbay AR; Ayaz S; Turhan H; Metin F; Ilkay E; Sabah I
Coron Artery Dis; 2007 Sep; 18(6):451-4. PubMed ID: 17700216
[TBL] [Abstract][Full Text] [Related]
20. Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease.
van Oost BA; Veldhuyzen BF; van Houwelingen HC; Timmermans AP; Sixma JJ
Thromb Haemost; 1982 Dec; 48(3):289-93. PubMed ID: 6187082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
